Catalyst

ABBV earnings

Jul 31, 2026

ABBV earnings — 2026-07-31

Reported the quarter ending 2026-06-30: revenue $16.99B, diluted EPS $2.03, net income $3.61B (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -4.8% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

6 events

DateTypeEvent

Jul 31 Market BriefOne Margin Call, One Record Day Jul 31 ScanBiotech Scan Jul 30 Market BriefThe Block Clears: Citadel Buys the Book, Memory Rips Jul 30 CatalystABBV earnings Jul 29 Market BriefThe Split Print: Compute Sellers Collect, Compute Buyers Pay Jul 28 ScanBiotech Scan

No direct external sources are attached to this read.